The results of another study on 196 genes in CRC patients determined that use of the expression pattern of main genes such as Annexin A3 (ANXA3), C-type lectin domain family 4 member M (CLEC4D), Lamin B (LMNB1), proline rich and Gla domain 4 (PRRG4), TNF alpha induced protein 6 (TNFAIP6), Lamin B1 (TNFAIP6), Vanin 1 (VNN1), and Interleukin 2 receptor subunit beta (IL2RB) that participate in tumour initiation and development could act as novel biomarkers for early detection of CRC [35]. Here, IL2RB is linked to neoplasm.